Virtus LifeSci Biotech Products ETF (BBP)

NYSEARCA: BBP · IEX Real-Time Price · USD
59.50
+1.02 (1.74%)
At close: Jun 24, 2024, 10:36 AM
59.52
+0.02 (0.03%)
After-hours: Jun 24, 2024, 6:30 PM EDT
1.74%
Assets $20.01M
Expense Ratio 0.79%
PE Ratio n/a
Shares Out 350,004
Dividend (ttm) n/a
Dividend Yield n/a
Ex-Dividend Date n/a
Payout Ratio n/a
1-Year Return +7.15%
Volume 213
Open 59.50
Previous Close 58.48
Day's Range 59.50 - 59.50
52-Week Low 45.00
52-Week High 63.25
Beta 0.90
Holdings 65
Inception Date Dec 17, 2014

About BBP

Fund Home Page

The Virtus LifeSci Biotech Products ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is issued by Virtus Investment Partners.

Asset Class Equity
Category Health
Region North America
Stock Exchange NYSEARCA
Ticker Symbol BBP
Index Tracked LifeSci Biotechnology Products Index

Top 10 Holdings

18.16% of assets
Name Symbol Weight
Sarepta Therapeutics, Inc. SRPT 2.06%
ImmunityBio, Inc. IBRX 1.98%
Mirum Pharmaceuticals, Inc. MIRM 1.93%
Intra-Cellular Therapies, Inc. ITCI 1.80%
Gilead Sciences, Inc. GILD 1.78%
Insmed Incorporated INSM 1.77%
United Therapeutics Corporation UTHR 1.76%
Day One Biopharmaceuticals, Inc. DAWN 1.70%
Axsome Therapeutics, Inc. AXSM 1.69%
TG Therapeutics, Inc. TGTX 1.69%
View More Holdings

News

Late-stage biotech ETFs rally Monday on virus treatment hopes

Late-stage biotech exchange-traded funds were among the day's biggest gainers Monday as investors pinned their hopes on medical responses to the novel coronavirus. The ALPS Medical Breakthroughs ETF ...

Other symbols: SBIO
4 years ago - Market Watch